WHWK
WHWK
NASDAQ · Biotechnology

Whitehawk Therapeutics Inc

$3.44
+0.16 (+4.88%)
As of Mar 31, 3:11 PM ET ·
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Buy 7 64%
Hold 4 36%
Sell 0 0%
Price Target
Analyst Price Target +403.2% upside
Low Target $14.24
Average Target $17.31
High Target $28.90
Current Price $3.44
Current
$3.44
Target
$17.31
$14.24 $17.31 avg $28.90
Scenario Analysis
Bear Case
$14.24
314.0%
Low target
Base Case
$17.31
+403.2%
Avg target
Bull Case
$28.90
+740.1%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$4.48
-23.2% from high
52-Week Low
$1.39
+147.5% from low
Target vs 52W High
$17.31
+286.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%